Current treatments for atrial fibrillation (AFib), a common heart condition characterized by fast and irregular beats that can lead to stroke and heart failure, have multiple side effects and are ineffective for preventing AFib recurrence.
Researchers find that targeting immune cells may help treat atrial fibrillation medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
The research from investigators at Massachusetts General Hospital detailing the production of white blood cells in patients with heart disease may pave the way for new therapeutics and strategies to protect cardiovascular health.
Researchers at Massachusetts General Hospital (MGH) recently studied aspects related to the production of white blood cells. Their findings shed new light on the important role played by the vascular bone marrow niche and how inflammation occurs, and may pave a way for new therapeutics and strategies to protect cardiovascular health.
High cholesterol and inflammation are key drivers of heart disease, and an inflamed buildup of lipids can cut off the blood supply through a coronary artery to cause a heart attack.